Recruiting

Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial

This study evaluates a new digital health program that uses artificial intelligence (AI) to help patients lower their blood pressure through personalized lifestyle recommendations. The program collects information about patients' daily habits and blood pressure readings, then uses AI to suggest lifestyle changes that may work best for each person. The study will measure how well this program works across different groups of patients and aims to improve the program design to make it more effective and easier to…

ClinicalTrials.gov IDNCT07725250
PhaseNA
Enrollment3000
SponsorNational Bureau of Economic Research, Inc.
Age18 Years and older
SexALL
I'm interested View official listing

Conditions studied

Hypertension

About this study

This study evaluates a new digital health program that uses artificial intelligence (AI) to help patients lower their blood pressure through personalized lifestyle recommendations. The program collects information about patients' daily habits and blood pressure readings, then uses AI to suggest lifestyle changes that may work best for each person. The study will measure how well this program works across different groups of patients and aims to improve the program design to make it more effective and easier to use. The program will be offered to diverse patients at UC San Diego Health, including people of different ages, genders, races/ethnicities, and economic backgrounds, as part of their regular healthcare services.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Stage I-II hypertension (average clinical readings of blood pressure over 140/90) * Adequate decisional capacity to make a choice about participating in this research study * Fully ambulatory (not requiring assistive device such as a cane, wheelchair, walker, etc.) Exclusion Criteria: * Pregnancy * Under age 18 years * Institutionalized individuals who are likely to be vulnerable * Dependent on supplemental oxygen

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-14.